Join the 'Roweepra' group to help and get support from people like you.
Posted 1 Sep 2016 by Drugs.com
THURSDAY, Sept. 1, 2016 – Women who take the new epilepsy drugs levetiracetam and topiramate during pregnancy don't run the risk of harming their infant's mental development, British researchers report. But the commonly prescribed anti-seizure drug valproate was linked with lower IQs in children, especially when taken at higher doses, researchers say. "The treatment of epilepsy in women who are considering a pregnancy or are pregnant involves optimizing the health of the mother as well as keeping the risk to the fetus as low as possible," said lead researcher Rebecca Bromley, a research fellow at the Institute for Human Development at the University of Manchester. In the study, children exposed to levetiracetam (Keppra) or topiramate (Topamax) in the womb did not differ from children not exposed to these drugs. And they had better outcomes than the children exposed to valproate ... Read more
Related support groups: Birth Control, Contraception, Emergency Contraception, Seizures, Topamax, Epilepsy, Keppra, Topiramate, Qsymia, Seizure Prevention, Postcoital Contraception, Levetiracetam, Seizure Prophylaxis, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Keppra XR, Status Epilepticus, West Syndrome, Lennox-Gastaut Syndrome, Trokendi XR, Topamax Sprinkle